We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
-3.33%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$9.4B
AUM Growth
-$1.47B
(-14%)
Cap. Flow
-$936M
Cap. Flow
% of AUM
-9.97%
Top 10 Holdings %
Top 10 Hldgs %
27.51%
Holding
1,295
New
171
Increased
621
Reduced
344
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$109M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$60M |
| 3 |
Qualcomm
QCOM
|
+$51.7M |
| 4 |
Texas Instruments
TXN
|
+$40M |
| 5 |
Microsoft
MSFT
|
+$37.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.72B |
| 2 |
Intel
INTC
|
+$70.3M |
| 3 |
KraneShares CSI China Internet ETF
KWEB
|
+$60.1M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$43.5M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.79% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 10.38% |
| 4 | Energy | 7.34% |
| 5 | Consumer Discretionary | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Fidelity National Information Services
FIS
$23.1B
| $6.23M | 0.07% |
82,435
+10,976
| +15% | +$1.02M |
|
|
DVAX
277
DELISTED
Dynavax Technologies
DVAX
| $6.21M | 0.07% |
594,817
+330,400
| +125% | +$4.31M |
|
278
Cytokinetics
CYTK
$10.5B
| $6.16M | 0.07% |
127,100
+30,443
| +31% | +$1.47M |
|
279
NetEase
NTES
$85.3B
| $6.15M | 0.07% |
81,366
+12,089
| +17% | +$1.06M |
|
|
BLUE
280
DELISTED
bluebird bio
BLUE
| $6.14M | 0.07% |
48,529
+35,416
| +270% | +$4.01M |
|
|
VERV
281
DELISTED
Verve Therapeutics
VERV
| $6.14M | 0.07% |
+178,767
| New | +$5.71M |
|
282
Coca-Cola
KO
$377B
| $6.13M | 0.07% |
+109,405
| New | +$6.8M |
|
283
Northern Trust
NTRS
$33.3B
| $6.12M | 0.07% |
71,579
+6,292
| +10% | +$607K |
|
284
JD.com
JD
$44.6B
| $6.11M | 0.07% |
121,547
+22,596
| +23% | +$1.34M |
|
|
SBNY
285
DELISTED
Signature Bank
SBNY
| $6.08M | 0.06% |
40,299
+9,220
| +30% | +$1.68M |
|
286
Union Pacific
UNP
$174B
| $6.08M | 0.06% |
31,220
+20,989
| +205% | +$4.64M |
|
287
Arrowhead Research
ARWR
$11.9B
| $6.08M | 0.06% |
183,967
+54,579
| +42% | +$2.2M |
|
288
Exelixis
EXEL
$13.3B
| $6.07M | 0.06% |
387,086
+176,621
| +84% | +$3.41M |
|
289
Mercado Libre
MELI
$95.2B
| $6.06M | 0.06% |
7,321
-2,934
| -29% | -$2.52M |
|
290
Antero Resources
AR
$11.1B
| $6.04M | 0.06% |
197,925
-77,581
| -28% | -$2.86M |
|
291
Insmed
INSM
$21.4B
| $6.01M | 0.06% |
279,080
+95,905
| +52% | +$2.3M |
|
|
BPMC
292
DELISTED
Blueprint Medicines
BPMC
| $6M | 0.06% |
91,090
+11,687
| +15% | +$751K |
|
293
Arcus Biosciences
RCUS
$3.55B
| $5.98M | 0.06% |
228,641
+73,585
| +47% | +$1.95M |
|
294
Vir Biotechnology
VIR
$1.46B
| $5.97M | 0.06% |
309,577
+144,410
| +87% | +$3.67M |
|
295
American Tower
AMT
$80.8B
| $5.97M | 0.06% |
27,794
+5,766
| +26% | +$1.48M |
|
296
Iovance Biotherapeutics
IOVA
$1.82B
| $5.93M | 0.06% |
618,685
+158,605
| +34% | +$1.83M |
|
297
Beam Therapeutics
BEAM
$2.63B
| $5.9M | 0.06% |
123,925
+2,952
| +2% | +$168K |
|
298
BridgeBio Pharma
BBIO
$15.7B
| $5.87M | 0.06% |
590,740
+137,660
| +30% | +$1.43M |
|
299
United Parcel Service
UPS
$88.6B
| $5.87M | 0.06% |
36,320
+25,757
| +244% | +$4.88M |
|
300
Celldex Therapeutics
CLDX
$2.99B
| $5.84M | 0.06% |
207,693
+83,887
| +68% | +$2.57M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Rafferty Asset Management held 1,295 positions worth $9.4B, down 14% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Rafferty Asset Management withdrew a net $936M in Q3 2022, closing 156 positions and reducing 344 holdings. Its most notable exit was iShares Russell 1000 Value ETF, an estimated $21.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Rafferty Asset Management opened a new position in American Express worth $28M.
- Rafferty Asset Management's largest Q3 2022 buy was American Express: 207,400 shares worth $28M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $109M increase.
- Rafferty Asset Management's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.72B.
- Rafferty Asset Management fully exited iShares Russell 1000 Value ETF in Q3 2022, selling an estimated $21.8M.
- Rafferty Asset Management's ten largest holdings make up 28% of its $9.4B portfolio in Q3 2022.
- Rafferty Asset Management opened 171 new positions and closed 156 in Q3 2022.
- Rafferty Asset Management's portfolio value fell 14% quarter-over-quarter to $9.4B.
Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.